US OptionsDetailed Quotes

ACCD241220C5000

Watchlist

0.10
0.000.00%

15min DelayClose Dec 13 16:00 ET

0.00High0.00Low

Accolade Stock Discussion

人间富贵花

Oct 25 09:43

$Accolade (ACCD.US)$ 🚀🚀🚀

zamshark

Oct 8 12:07

hehehe

done jelly fish...

Share Your Profit/Loss

Jaguar8

Oct 8 06:03

NEWS ER

$Accolade (ACCD.US)$
Accolade Announces Results for Fiscal Second Quarter 2025
Accolade (NASDAQ: ACCD) announced financial results for fiscal Q2 2025 ended August 31, 2024. Revenue increased 10% to $106.4 million, while net loss improved 27% to $23.9 million. Non-GAAP Adjusted EBITDA loss narrowed 68% to $2.8 million, and Adjusted Gross Margin expanded to 47.3%.
CEO Rajeev Singh stated that Accolade is positioned to deliver its first full year of Adjusted EBITDA profitability and positiv...

Stock_Drift

Oct 8 04:26

🚨 Pre Market Ticks 5:24am EST 10/8 🚨

$X4 Pharmaceuticals (XFOR.US)$ $The E.W. Scripps (SSP.US)$ $Leafly (LFLY.US)$ $Short FTSE China 25 Proshares (YXI.US)$ $Accolade (ACCD.US)$ $Oragenics (OGEN.US)$ $Virios Therapeutics (VIRI.US)$ $ProShares UltraShort FTSE China 50 (FXP.US)$ $Direxion Daily FTSE China Bear 3X Shares ETF (YANG.US)$ $Nuburu (BURU.US)$ $Ontrak (OTRK.US)$ $Nature's Miracle (NMHI.US)$

Stock_Drift

Oct 8 03:27

Early Pre_Market Ticks 4:25am EST. 10/8/24🚨🚨

$BigBear.ai Holdings (BBAI.US)$ $Super Micro Computer (SMCI.US)$ $ProShares UltraShort Bitcoin ETF (SBIT.US)$ $Proshares Ultrashort Silver (ZSL.US)$ $Accolade (ACCD.US)$ $The E.W. Scripps (SSP.US)$ $Defiance Daily Target 2X Long SMCI ETF (SMCX.US)$ $Short FTSE China 25 Proshares (YXI.US)$ $ProShares UltraShort FTSE China 50 (FXP.US)$ $Ontrak (OTRK.US)$ $Direxion Daily FTSE China Bear 3X Shares ETF (YANG.US)$ $Nuburu (BURU.US)$

Stock_Drift

Oct 7 21:01

Pre_Market Earnings. 10/8/24

$PepsiCo (PEP.US)$ $Accolade (ACCD.US)$

Iwanttolive

Jul 1 00:51

$Accolade (ACCD.US)$ lol now competition to cut target price.

Moomoo AI

Mar 5 06:51

Accolade's balance sheet seems manageable with its US$741.6m market cap, but needs monitoring. Its future profitability will impact its financial strength. However, its EBIT loss, negative free cash outflow of US$37m, and a US$123m accounting loss make it somewhat risky.

Health Check: How Prudently Does Accolade (NASDAQ:ACCD) Use Debt?

Moomoo AI

Dec 25, 2023 06:26

Investors seem to be banking on Accolade's strong future outlook, despite its slow growth in revenue. The high P/S ratio and share price suggest confidence in the company's future revenues.

Accolade, Inc. (NASDAQ:ACCD) Looks Just Right With A 44% Price Jump

Moomoo Breakfast US

Jul 1, 2022 07:35

Columns Today's pre-market stock movers: KSS, NIO, MU, LULU and more

Gainers:
• $Cytokinetics (CYTK.US)$ +8.7% (prices offering of of $450.0 mln of 3.50% convertible senior notes due 2027)
• $XPeng (XPEV.US)$ +3.4% (June deliveries)
• $NIO Inc (NIO.US)$ +2.9% (June deliveries)
• $Bitfarms (BITF.US)$ +2.7% (provides June 2022 production and mining operations update)
• $Accolade (ACCD.US)$ +2.7% (In reaction to earnings/guidance)
• $BioCryst Pharmaceuticals (BCRX.US)$ +2.6% (presents new data demonstrating...

No comment yet